Skip to main content
Brandon Hardesty, MD, Hematology, Indianapolis, IN

BrandonHardestyMD(He/Him)

Hematology • Indianapolis, IN

Clotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias

Adult Hematologist

Join to view full profile

Dr. Hardesty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hardesty's full profile

Already have an account?

  • Office

    8326 Naab Road
    Indianapolis, IN 46260
    Phone+1 317-871-0000
    Fax+1 317-871-0010

Summary

  • Dr. Brandon Hardesty is a Hematology specialist based in Indianapolis, Indiana with subspecialties in Hemophilia & Bleeding Disorder, and Sickle Cell & Other Anemias. He completed his fellowship in Hematology and Medical Oncology, as well as his residency in Internal Medicine, at Indiana University School of Medicine and is an alumnus of Ohio State University College of Medicine. He is currently a Clinical Assistant professor at Marian University College of Osteopathic Medicine and an Adult Hematologist at Indiana Hemophilia & Thrombosis Center. Dr. Hardesty has expertise in managing conditions like sickle-cell anemia, bleeding disorders, and plasminogen deficiency, and has contributed to multiple clinical trials and publications within these fields. He was recognized as a Top Doctor by Castle Connolly from 2019 to 2023.

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Internal Medicine, 2006 - 2009
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2006

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2008 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top Doctor Castle Connolly, 2019-2024

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Cardiovascular Disease Prevention in Persons with Hemophilia
    Brandon Hardesty, Joel Bowen, Suman Sood, Craig Kessler, MaissaaJanbain, Miguel Escobar, Doris Quon, American Society of Hematology, New Orleans, LA, 12/12/2022
  • Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia
    Hardesty, BM; Plum, S; Thibaudeau, K; Lee, M; Thukral, N; Shapiro, AD, American Society of Hematology, Orlando, FL, 12/7/2015
  • Lineage-specific Chimerism Analysis of Post-infusion, Pre-engraftment Sorted Peripheral Blood Cells after Minimal Intensity Allotransplantation
    Hardesty, Brandon M; Pike, Jason; Al Baghdadi, Tareq; Srivastava, Shivani; Schwartz, Jennifer E; Robertson, Michael J; Rojas, Luis A; Wood, Lisa L; Abonour, Rafat; Far..., Federation of Clinical Immunology Societies, Vancouver, Canada
  • Join now to see all

Lectures

  • Introduction to Hemophilia Gene Therapy 
    Virtual - 9/2023
  • Surgical Prophylaxis in vWD: Maintaining the Balance 
    World Federation of Hemophilia Orlando, FL - 7/25/2016
  • Emergency Management of the Bleeding Patient 
    Memorial Hospital of South Bend - 4/29/2015
  • Join now to see all

Other

Authored Content

  • Plasminogen Deficiency6/1/2018

Press Mentions

  • Pharmaceutical companies seek FDA approval for new sickle cell cure via gene therapy
    Pharmaceutical companies seek FDA approval for new sickle cell cure via gene therapyOctober 31st, 2023
  • Advocates Raising Awareness of Sickle Cell Disease
    Advocates Raising Awareness of Sickle Cell DiseaseFebruary 10th, 2024

Grant Support

  • Indiana Sickle Cell Data Collection ProgramCenters for Disease Control2023–2028
  • Sickle Cell Treatment Demonstration Program Regional CollaborativeDepartment of Health and Human Services, Health Resources & Services Administration2014–2025
  • Prospective Management of Cardiovascular DiseaseBayer Healthcare Pharmaceuticals, Inc2020–2023

Committees

  • Member, MASAC Geriatric Workgroup 2024 - 2024

Professional Memberships

Industry Relationships

  • Consultant, PSI CRODisclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center.2023 - Present
  • Travel and Research support, Global Blood TherapeuticsDisclosure: All fees and honoraria are donated to the Indiana Hemophilia and Thrombosis Center.2017 - 2017
  • Research, Travel, Advisory Board, and Speaker, Shire Pharmaceuticals (formerly Baxalta)Disclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center.2015 - 2017
  • Consultant, Travel, and Advisory Board, Novo NordiskDisclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center2014 - 2017
  • Consultant, OctapharmaDisclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center.2016 - 2016
  • Research Funding, ProMetic Biotherapeutics2015 - 2016
  • Consultant, BiogenDisclosure: All fees are donated to the Indiana Hemophilia and Thrombosis Center.2015 - 2015

External Links

  • LinkedInhttp://www.linkedin.com/pub/brandon-hardesty-md/a0/a70/316/
  • IHTChttp://www.ihtc.org
  • ResearchGatehttps://www.researchgate.net/profile/Brandon_Hardesty

Dr. Brandon Hardesty, Dr. Brandon Hardesty, MD, Dr. B Hardesty